Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $55.25 USD
Change Today -0.75 / -1.34%
Volume 656.7K
CPHD On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael F. Sarosdy M.D.

Member of Scientific Advisory Board, Cepheid
AgeTotal Calculated CompensationThis person is connected to 15 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Michael F. Sarosdy,MD served as Chief of Division of Urologic Surgery at UT San Antonio Health Science Center and Director of the South Texas Prostate Cancer Program at the San Antonio Cancer Institute. Dr. Sarosdy has been Member of Scientific Advisory Board of Cepheid since September 12, 2007. Dr. Sarosdy is a Board-certified Urologic Surgeon at the Cancer Therapy and Research Center, San Antonio, TX.

Corporate Headquarters*

904 Caribbean Drive
Sunnyvale, California 94089

United States

Phone: 408-541-4191
Fax: 408-541-4192

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CPHD:US $55.25 USD -0.75

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Douglas C. Bryant Chief Executive Officer, President and Director
Quidel Corp.
$524.4K
John A. Krauetler Chairman of The Board, Chief Executive Officer and President
Meridian Bioscience, Inc.
$602.9K
Nachum Shamir Chief Executive Officer and President
Luminex Corporation
$275.0K
Carlo Rosa Chief Executive Officer, General Manager and Executive Director
DiaSorin S.p.A.
€561.3K
Jong-Yoon Cheon Founder, Chief Executive Officer and Chief Technology Officer
Seegene, Inc.
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CEPHEID INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.